ARCHIVES

UCSD Center Designated Comprehensive; Siteman Center In St. Louis Wins Core Grant.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

Gleevec Approved For Pediatric CML

May 23, 2003

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

Funding Opportunities.

July 19, 2002

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002